BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12063263)

  • 21. Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops.
    Rubin C; Litvak V; Medvedovsky H; Zwang Y; Lev S; Yarden Y
    Curr Biol; 2003 Feb; 13(4):297-307. PubMed ID: 12593795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor.
    Levkowitz G; Waterman H; Zamir E; Kam Z; Oved S; Langdon WY; Beguinot L; Geiger B; Yarden Y
    Genes Dev; 1998 Dec; 12(23):3663-74. PubMed ID: 9851973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abl tyrosine kinase regulates endocytosis of the epidermal growth factor receptor.
    Tanos B; Pendergast AM
    J Biol Chem; 2006 Oct; 281(43):32714-23. PubMed ID: 16943190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-Cbl is inducibly tyrosine-phosphorylated by epidermal growth factor stimulation in fibroblasts, and constitutively tyrosine-phosphorylated and associated with v-Src in v-src-transformed fibroblasts.
    Odai H; Sasaki K; Hanazono Y; Ueno H; Tanaka T; Miyagawa K; Mitani K; Yazaki Y; Hirai H
    Jpn J Cancer Res; 1995 Dec; 86(12):1119-26. PubMed ID: 8635998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-Cbl ubiquitinates the EGF receptor at the plasma membrane and remains receptor associated throughout the endocytic route.
    de Melker AA; van der Horst G; Calafat J; Jansen H; Borst J
    J Cell Sci; 2001 Jun; 114(Pt 11):2167-78. PubMed ID: 11493652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reciprocal regulation of the ubiquitin ligase Itch and the epidermal growth factor receptor signaling.
    Azakir BA; Angers A
    Cell Signal; 2009 Aug; 21(8):1326-36. PubMed ID: 19341794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases.
    Kowanetz K; Crosetto N; Haglund K; Schmidt MHH; Heldin CH; Dikic I
    J Biol Chem; 2004 Jul; 279(31):32786-95. PubMed ID: 15159412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function.
    Fong CW; Leong HF; Wong ES; Lim J; Yusoff P; Guy GR
    J Biol Chem; 2003 Aug; 278(35):33456-64. PubMed ID: 12815057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of the ligand-mediated down-regulation of epidermal growth factor receptor by Ymer, a novel tyrosine-phosphorylated and ubiquitinated protein.
    Tashiro K; Konishi H; Sano E; Nabeshi H; Yamauchi E; Taniguchi H
    J Biol Chem; 2006 Aug; 281(34):24612-22. PubMed ID: 16803894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic analysis of the epidermal growth factor receptor (EGFR) interactome and post-translational modifications associated with receptor endocytosis in response to EGF and stress.
    Tong J; Taylor P; Moran MF
    Mol Cell Proteomics; 2014 Jul; 13(7):1644-58. PubMed ID: 24797263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor.
    Timpson P; Lynch DK; Schramek D; Walker F; Daly RJ
    Cancer Res; 2005 Apr; 65(8):3273-80. PubMed ID: 15833860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl.
    Thien CB; Langdon WY
    Oncogene; 1997 Dec; 15(24):2909-19. PubMed ID: 9416834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.
    Visser GD; Lill NL
    Exp Cell Res; 2005 Dec; 311(2):281-93. PubMed ID: 16246327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
    Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
    J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation.
    Ono M; Hirata A; Kometani T; Miyagawa M; Ueda S; Kinoshita H; Fujii T; Kuwano M
    Mol Cancer Ther; 2004 Apr; 3(4):465-72. PubMed ID: 15078990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conjugation to Nedd8 instigates ubiquitylation and down-regulation of activated receptor tyrosine kinases.
    Oved S; Mosesson Y; Zwang Y; Santonico E; Shtiegman K; Marmor MD; Kochupurakkal BS; Katz M; Lavi S; Cesareni G; Yarden Y
    J Biol Chem; 2006 Aug; 281(31):21640-21651. PubMed ID: 16735510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration.
    Frey MR; Dise RS; Edelblum KL; Polk DB
    EMBO J; 2006 Dec; 25(24):5683-92. PubMed ID: 17139251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A tale of two Cbls: interplay of c-Cbl and Cbl-b in epidermal growth factor receptor downregulation.
    Pennock S; Wang Z
    Mol Cell Biol; 2008 May; 28(9):3020-37. PubMed ID: 18316398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl.
    Hall AB; Jura N; DaSilva J; Jang YJ; Gong D; Bar-Sagi D
    Curr Biol; 2003 Feb; 13(4):308-14. PubMed ID: 12593796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated Cdc42 sequesters c-Cbl and prevents EGF receptor degradation.
    Wu WJ; Tu S; Cerione RA
    Cell; 2003 Sep; 114(6):715-25. PubMed ID: 14505571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.